{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:56:39Z","timestamp":1782752199976,"version":"3.54.5"},"reference-count":20,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","award":["2021-HQ-000059"],"award-info":[{"award-number":["2021-HQ-000059"]}],"id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Nurs Res"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>With nearly 50,000 people having died since 2016 as a result of the unregulated toxic drug supply, novel approaches to care are needed. A small number of Safer Stimulant Supply programs have been piloted in Canada, which seek to provide a pharmaceutical-grade stimulant medication replacement for the toxic unregulated stimulant supply. In this paper, we describe the results of retrospective Safer Stimulant Supply program medical chart reviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We extracted data from program intake and check-in forms collected on an ongoing basis by the clinical teams. In total, 28 medical charts were included in this evaluation. Data collected was reported using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Chart reviews showed that over the course of the program, program participants reported an overall decrease in their unregulated stimulant use. Specifically, at program intake and check-in appointments, cocaine use went from a median of 10 points\/day to 0 points\/day, and crystal methamphetamine use went from a median of 1.5 points\/day to 0 points\/day. Chart reviews also showed that program participants reported increased access to primary care and infectious disease programs and improvements in housing status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our research demonstrated that program participants found Safer Stimulant Supply programs to be impactful in addressing ongoing drug use. Safer Stimulant Supply programs remain an underutilized but important harm reduction tool to address the drug poisoning crisis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08445621251314227","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T13:15:09Z","timestamp":1738156509000},"page":"324-329","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Safer Stimulant Supply: Program Outcomes"],"prefix":"10.1177","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-6718","authenticated-orcid":false,"given":"Marlene","family":"Haines","sequence":"first","affiliation":[{"name":"University of Ottawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"O\u2019Byrne","sequence":"additional","affiliation":[{"name":"University of Ottawa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"e_1_3_2_2_1","volume-title":"Why some men in the trades are dying of opioid overdoses","author":"Aldous J.","year":"2023","unstructured":"Aldous J., Turner C., Simmons T. (2023, February 9). Why some men in the trades are dying of opioid overdoses. Canadian Broadcasting Corporation."},{"key":"e_1_3_2_3_1","unstructured":"British Columbia Centre on Substance Use. (2022). Risk mitigation in the context of dual public health emergencies. https:\/\/www.bccsu.ca\/wp-content\/uploads\/2022\/02\/Risk-Mitigation-Guidance-Update-February-2022.pdf"},{"key":"e_1_3_2_4_1","unstructured":"Canadian Association of People Who Use Drugs. (2019). Safe supply: Concept document. https:\/\/www.capud.ca\/capud-resources\/safe-supply-projects"},{"key":"e_1_3_2_5_1","unstructured":"Centre on Drug Policy Evaluation. (2023). What\u2019s in Toronto drug supply?https:\/\/drugchecking.cdpe.org"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthplace.2020.102327"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0351-1"},{"key":"e_1_3_2_8_1","unstructured":"Gomes T. Murray R. Kolla G. Leece P. Kitchen S. Campbell T. Besharah J. Cahill T. Garg R. Iacono A. Munro C. Nunez E. Robertson L. Shearer D. Singh S. Toner L. Watford J. (2022). Patterns of medication and healthcare use among people who died of an opioid-related toxicity during the COVID-19 pandemic in Ontario (Issue January). https:\/\/odprn.ca\/research\/publications\/opioid-related-deaths-and-healthcare-use\/"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00776-z"},{"key":"e_1_3_2_10_1","unstructured":"Haines M. Tefoglou A. O\u2019Byrne P. (2022). Safer supply Ottawa evaluation: Fall 2022 report. https:\/\/safersupplyottawa.com\/research\/"},{"key":"e_1_3_2_11_1","unstructured":"Haines M. Tefoglou A. O\u2019Byrne P. (2023). Safer supply Ottawa evaluation: Spring 2023 report. https:\/\/safersupplyottawa.com\/research\/"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.10.020"},{"key":"e_1_3_2_13_1","unstructured":"Health Canada. (2021). Canadian Alcohol and Drugs Survey (CADS): Summary of results for 2019. https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2019-summary.html#a3"},{"key":"e_1_3_2_14_1","unstructured":"Health Canada. (2023). Substance use and addictions program active projects. https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/canadian-drugs-substances-strategy\/funding\/substance-use-addictions-program\/active-projects.html"},{"key":"e_1_3_2_15_1","unstructured":"Health Quality Ontario. (2022). Primary care performance in Ontario. https:\/\/www.hqontario.ca\/System-Performance\/Primary-Care-Performance"},{"key":"e_1_3_2_16_1","unstructured":"Iacono A. Kolla G. Yang J. Leece P. Moumita T. Wu F. Cheng C. Campbell T. Antoniou T. Juurlink D. Sheikh H. Emblem J. Kurdyak P. Bertrand J. Shearer D. Singh S. Gomes T. (2023). Opioid toxicity and access to treatment among adolescents and young adults in Ontario. https:\/\/odprn.ca\/research\/publications\/opioids-among-adolescents-and-young-adults\/"},{"key":"e_1_3_2_17_1","unstructured":"Kampman K. (2022). Approach to treatment of stimulant use disorder in adults. In UpToDate. https:\/\/www.uptodate.com\/contents\/approach-to-treatment-of-stimulant-use-disorder-in-adults?search=stimulant%20use&source=search_result&selectedTitle=2\u223c150&usage_type=default&display_rank=2#H3614536271"},{"key":"e_1_3_2_18_1","unstructured":"National Safer Supply Community of Practice. (2023). Prescribed safer supply: Frequently asked questions. https:\/\/www.nss-aps.ca\/sites\/default\/files\/resources\/2023-05-25-PrescribedSaferSupply_FAQ_NSSCoP.pdf"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-8080(08)31345-7"},{"key":"e_1_3_2_20_1","unstructured":"Public Health Agency of Canada. (2024 March). Opioid- and stimulant-related harms in Canada. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"key":"e_1_3_2_21_1","unstructured":"Special Advisory Committee on the Epidemic of Opioid Overdoses. (2022). Men in trades: The opioid overdose crisis in Canada. https:\/\/www.canada.ca\/en\/services\/health\/campaigns\/men-construction-trades-overdose-crisis-canada.html"}],"container-title":["Canadian Journal of Nursing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08445621251314227","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08445621251314227","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08445621251314227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:22:56Z","timestamp":1777389776000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08445621251314227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/08445621251314227"],"URL":"https:\/\/doi.org\/10.1177\/08445621251314227","relation":{},"ISSN":["0844-5621","1705-7051"],"issn-type":[{"value":"0844-5621","type":"print"},{"value":"1705-7051","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]}}}